Aortic stenosis: A contemporary review

American Journal of the Medical Sciences

Volumn 343, Issue 6, 2012, Pages 490-496

  Sawaya, Fadi ^a   Liff, David ^a   Stewart, Jim ^a   Lerakis, Stamatios ^a   Babaliaros, Vasilis ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Aortic stenosis; Aortic valve; Percutaneous; Transcatheter

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM; EZETIMIBE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; ROSUVASTATIN; SIMVASTATIN;

ANGINA PECTORIS; AORTA ATHEROSCLEROSIS; AORTA BALLOON; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTIC VALVE REPAIR; ARTERY CALCIFICATION; ASYMPTOMATIC DISEASE; BICUSPID AORTIC VALVE; CARDIOMYOPATHY; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; ELECTROCARDIOGRAM; GENERAL CONDITION DETERIORATION; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFE EXPECTANCY; PHYSICAL EXAMINATION; PROGNOSIS; REVIEW; RHEUMATIC HEART DISEASE; SMOKING; SURVIVAL; SYSTOLE; SYSTOLIC HEART MURMUR; THORAX PAIN; THORAX RADIOGRAPHY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; VASCULAR RESISTANCE;

EID: 84862847120     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182539d70     Document Type: Article

References (51)

1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-4. (Pubitemid 27116107)
2. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 2003;24:1231-43. (Pubitemid 36834640)
3. Otto CM. Calcific aortic stenosis-time to look more closely at the valve. N Engl J Med 2008;359:1395-8.
4. O'Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 2006;26:1721-8. (Pubitemid 44305324)
5. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-26. (Pubitemid 40875006)
6. Huntington K, Hunter AG, Chan KL. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol 1997;30:1809-12. (Pubitemid 27521266)
7. Roberts WC. Anatomically isolated aortic valvular disease. The case against its being of rheumatic etiology. Am J Med 1970;49:151-9.
8. Ozumi K, Tasaki H, Yamashita K, et al. Valvular and supravalvular aortic stenosis in heterozygous familial hypercholesterolemia, a case report. J Atheroscler Thromb 2005;12:289-93.
9. Umana E, Ahmed W, Alpert MA. Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci 2003;325: 237-42. (Pubitemid 36437996)
10. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968;38(suppl 1): 61-7.
11. Gould KL, Carabello BA. Why angina in aortic stenosis with normal coronary arteriograms? Circulation 2003;107:3121-3. (Pubitemid 36793078)
12. Schwartz LS, Goldfischer J, Sprague GJ, et al. Syncope and sudden death in aortic stenosis. Am J Cardiol 1969;23:647-58.
13. Richards AM, Nicholls MG, Ikram H, et al. Syncope in aortic valvular stenosis. Lancet 1984;2:1113-6. (Pubitemid 15210845)
14. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 2005;26:1790-6. (Pubitemid 41222328)
15. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-9. (Pubitemid 36886240)
16. Januzzi JL, Isselbacher EM, Fattori R, et al. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol 2004;43: 665-9. (Pubitemid 38229542)
17. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5. (Pubitemid 40875002)
18. Lombard JT, Selzer A. Valvular aortic stenosis. A clinical and hemodynamic profile of patients. Ann Intern Med 1987;106:292-8. (Pubitemid 17009892)
19. Stoddard MF, Hammons RT, Longaker RA. Doppler transesophageal echocardiographic determination of aortic valve area in adults with aortic stenosis. Am Heart J 1996;132:337-42. (Pubitemid 26292399)
20. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-7. (Pubitemid 29325741)
21. Novaro GM, Katz R, Aviles RJ, et al. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007;50: 1992-8. (Pubitemid 350046337)
22. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343: 611-7. (Pubitemid 30659472)
23. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.
24. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/ AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol 2010;55: e27-129.
25. Novaro GM, Tiong IY, Pearce GL, et al. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104:2205-9. (Pubitemid 33043301)
26. Bellamy MF, Pellikka PA, Klarich KW, et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002;40:1723-30. (Pubitemid 35341948)
27. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007;49:554-61. (Pubitemid 46177435)
28. Chan KL, Teo K, Dumesnil JG, et al. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121:306-14.
29. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97. (Pubitemid 40958435)
30. Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359:1343-56.
31. O'Brien KD, Zhao XQ, Shavelle DM, et al. Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function. J Investig Med 2004;52:185-91. (Pubitemid 38856421)
32. Popovic ZB, Khot UN, Novaro GM, et al. Effects of sodium nitroprusside in aortic stenosis associated with severe heart failure: pressurevolume loop analysis using a numerical model. Am J Physiol Heart Circ Physiol 2005;288:H416-23. (Pubitemid 40023874)
33. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation 1982;66:1105-10. (Pubitemid 12036848)
34. Brown JM, O'Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009;137:82-90.
35. Kvidal P, Bergström R, Malm T, et al. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J 2000;21:1099-111. (Pubitemid 30352994)
36. Stahle E, Kvidal P, Nyström SO, et al. Long-term relative survival after primary heart valve replacement. Eur J Cardiothorac Surg 1997;11: 81-91. (Pubitemid 27076118)
37. Sharma UC, Barenbrug P, Pokharel S, et al. Systematic review of the outcome of aortic valve replacement in patients with aortic stenosis. Ann Thorac Surg 2004;78:90-5. (Pubitemid 38833906)
38. Vaquette B, Corbineau H, Laurent M, et al. Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome. Heart 2005;91:1324-9. (Pubitemid 41360953)
39. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994;89:642-50. (Pubitemid 24056191)
40. Rahimtoola SH. Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role. J Am Coll Cardiol 1994;23:1076-8. (Pubitemid 24117138)
41. Letac B, Cribier A, Eltchaninoff H, et al. Evaluation of restenosis after balloon dilatation in adult aortic stenosis by repeat catheterization. Am Heart J 1991;122:55-60.
42. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20. (Pubitemid 41746694)
43. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
44. Webb JG, Altwegg L, Masson JB, et al. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 2009; 53:1855-8.
45. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
46. Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 2009;53: 1883-91.
47. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
48. Bauer F, Lemercier M, Zajarias A, et al. Immediate and longterm echocardiographic findings after transcatheter aortic valve implantation for the treatment of aortic stenosis: the Cribier-Edwards/ Edwards-Sapien valve experience. J Am Soc Echocardiogr 2010;23: 370-6.
49. Gurvitch R, Wood DA, Tay EL, et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010;122: 1319-27.
50. Babaliaros VC. Front stroke, back stroke: the "emerging" interest of stroke in transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010;3:1139-40.
51. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364: 2187-98.